Consequently, they found that cells transfected with miR-433 associated decreased Rap1a protein levels along with slightly lowered Rap1a mRNA levels, thus demonstrating that, by targeting the RAP1A gene and subsequently activating the MAPK signaling pathway, miR-433 behaves as a tumor suppressor (76). The gene discussed is RAP1A; the disease is neoplasm.